Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient
Asad Makhani,1 Miriam Thake,2 William Gibson1 1University of Alberta, Division of Geriatric Medicine, Edmonton, Alberta, Canada; 2Great Western Hospitals NHS Foundation Trust, Swindon SN3 6BB, UKCorrespondence: William GibsonUniversity of Alberta, Division of Geriatric Medicine, 1-198 Clinical Scien...
Enregistré dans:
| Auteurs principaux: | Makhani A, Thake M, Gibson W |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b65e6b143e1944148ed126181816220e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder
par: Araklitis G, et autres
Publié: (2020) -
The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
par: Danny Ulahannan, et autres
Publié: (2009) -
Acupuncture for Treatment of Overactive Bladder
par: Maryam Hosseini, et autres
Publié: (2021) -
Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
par: Bilal Chughtai, et autres
Publié: (2008) -
Update on duloxetine for the management of stress urinary incontinence
par: Maya Basu, et autres
Publié: (2008)